tirzepatide for type 2 diabetes FDA approves tirzepatide, Eli Lilly's new drug, and the company shares an estimated price At a glance factsheet: Tirzepatide

(2022) 54:e14309

CunhaDALadrireLOrtisFIgoillo-EsteveMGurzovENLupiRet al

The presence of neurological complications substantially affects response time

Only people with severe sickle cell disease who also have comorbidities such as priapism, acute chest syndrome, nephropathy, retinopathy, osteonecrosis of multiple joints, and exchange transfusions are eligible for hematopoietic stem cell transplants

Podocytes are new cellular targets of haemoglobin-mediated renal damage

David: Spanning a century of reporting from C&EN, this podcast traces discoveries from our past Gina: to how they shape our present David: and will change our future